{"id":"73823d83-172b-4f1f-9730-e739c322d9cd","modelId":"c156c3ce-ec4e-496e-aeef-28a6a9af4e77","versionId":null,"locationId":"63e09f85-2dc7-4e87-a172-6f58dcb3673a","operatorId":"06e82f4d-e2d5-4a09-a089-c752f2f22056","ownerId":null,"slug":"endoquest-els-boston-massachusetts-usa","status":"pilot","firstSeen":"2022-08-01T00:00:00.000Z","statusChangeReason":null,"contractType":null,"pilotOutcome":null,"endedAt":null,"unitsOnSite":null,"tasksPerformed":["surgical_assistance"],"shiftStructure":null,"hoursPerDay":8,"siteType":"hospital","operatorConfirmed":null,"humanSupervisionOnsite":null,"locationPrecisionTier":"verified_coordinates","deploymentScale":"small_2_10","siteEnvironment":"indoor","operatorType":null,"sourceQualityTier":2,"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://www.prnewswire.com/news-releases/endoquest-robotics-announces-installation-of-the-first-endoluminal-surgical-system-to-advance-the-clinical-and-procedural-development-of-the-els-system-at-brigham-and-womens-hospital-in-boston-massachusetts-301615110.html","name":"PR Newswire","title":"EndoQuest Robotics Announces Installation of the First Endoluminal Surgical System at Brigham and Women's Hospital"}],"notes":"EndoQuest announced installation of the first ELS System at Brigham and Women's Hospital in August 2022. BWH designated as first Center of Excellence and training facility, and center for planned IDE clinical study (PARADIGM trial).","keyFacts":[],"reviewNote":null,"exposureHours":null,"deploymentMilesEstimate":null,"exposureBasis":null,"customerSegment":"healthcare","scaleTier":"pilot_lt10","contractValueUsd":null,"contractValueBasis":null,"customerCompanyId":null,"customerExternalName":null,"createdAt":"2026-08-08T22:32:46.726Z","updatedAt":"2026-08-21T14:22:31.386Z","model":{"id":"c156c3ce-ec4e-496e-aeef-28a6a9af4e77","companyId":"06e82f4d-e2d5-4a09-a089-c752f2f22056","modelName":"Endoluminal Surgical (ELS) System","slug":"endoquest-els","description":"Endoluminal Surgical (ELS) System is a surgical robot from EndoQuest Robotics, currently in pilot deployment.","formFactor":"surgical","industryVertical":null,"environment":null,"maturityStage":"pilot","lifecycleState":"active","supersededByModelId":null,"specs":{},"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://www.massdevice.com/endoquest-gets-fda-green-light-to-initiate-final-stage-of-surgical-robot-trial/","title":"EndoQuest FDA green light PARADIGM","sourceName":"MassDevice","dateAccessed":"2026-07-22"},{"url":"https://finance.yahoo.com/news/endoquest-robotics-secures-series-d-120000732.html","title":"EndoQuest Series D-2 Funding","sourceName":"Yahoo Finance/GlobeNewswire","dateAccessed":"2026-07-22"},{"url":"https://www.businesswire.com/news/home/20260112765182/en/EndoQuest-to-Bring-AI-Powered-Vision-and-Precision-to-Endoluminal-Robotic-Surgery-with-NVIDIA-IGX-Thor","title":"EndoQuest NVIDIA IGX Thor","sourceName":"BusinessWire","dateAccessed":"2026-07-22"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"manufacturerTermForTeleop":null,"keyFacts":[{"label":"PARADIGM trial (reported, Jan 2026)","value":"Enrolled 50 subjects at five US sites: HCA Houston, Mayo Clinic Scottsdale, Cleveland Clinic, Brigham and Women's, and AdventHealth Orlando, per MassDevice."},{"label":"Clinical milestones (reported, Jan 2026)","value":"FDA IDE in Dec 2024; first colorectal cases May 2025; first fully robotic ESD by a gastroenterologist in an IDE trial Oct 2025."},{"label":"Funding (reported, Jan 2026)","value":"EndoQuest had raised $42 million more than a year before the January 2026 report."}],"createdAt":"2026-07-22T23:21:51.831Z","updatedAt":"2026-10-10T04:58:12.482Z","unitsInFieldClaimed":null,"unitsInFieldVerified":null,"unitsManufacturedClaimed":null,"unitsManufacturedVerified":null,"unitsAsOf":null,"unitsSource":null,"salesModel":null,"priceUndisclosedSince":null,"autonomyClass":null,"autonomyStatement":null,"autonomyStatementSource":null,"demoForensics":null,"exportControlClass":null,"minCommitment":null,"warrantyTerms":null,"serviceModel":null,"productionRateClaimed":null,"productionRateEvidenced":null,"teleopRatioDisclosed":null,"interventionRateDisclosed":null,"company":{"id":"06e82f4d-e2d5-4a09-a089-c752f2f22056","name":"EndoQuest Robotics","slug":"endoquest","description":"Houston-based endoluminal robotic surgery company. CEO Eduardo Fonseca. Endoluminal Surgical (ELS) System — flexible robot for scar-free procedures through natural orifices. PARADIGM Trial: FDA-approved final stage (Jan 2026), 50 patients, 5 US centers (Brigham, Mayo, Cleveland Clinic, AdventHealth, HCA). First robotic ESD by gastroenterologist in IDE trial (Oct 2025). Series D-2 co-led by Crescent Enterprises + Dr. Fred Moll ([Intuitive surgical](/companies/intuitive-surgical) co-founder). NVIDIA IGX Thor integration for AI vision. $176M total raised.","status":"private","founded":null,"hq":"Houston, TX","hqLat":29.7589382,"hqLng":-95.3676974,"hqGeocodedAt":"2026-08-05T14:28:12.044Z","hqAddress":null,"hqPrecision":null,"website":"endoquestrobotics.com","fundingTotal":"176000000","type":"hardware","roles":["robot_maker","robot_operator"],"reviewStatus":"reviewed","heatIndex":77,"lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://www.massdevice.com/endoquest-gets-fda-green-light-to-initiate-final-stage-of-surgical-robot-trial/","title":"EndoQuest FDA green light PARADIGM","sourceName":"MassDevice","dateAccessed":"2026-07-22"},{"url":"https://finance.yahoo.com/news/endoquest-robotics-secures-series-d-120000732.html","title":"EndoQuest Series D-2 Funding","sourceName":"Yahoo Finance/GlobeNewswire","dateAccessed":"2026-07-22"},{"url":"https://www.businesswire.com/news/home/20260112765182/en/EndoQuest-to-Bring-AI-Powered-Vision-and-Precision-to-Endoluminal-Robotic-Surgery-with-NVIDIA-IGX-Thor","title":"EndoQuest NVIDIA IGX Thor","sourceName":"BusinessWire","dateAccessed":"2026-07-22"}],"keyFacts":[{"label":"Product","value":"Endoluminal Surgical (ELS) System, flexible endoluminal robot"},{"label":"Trial","value":"PARADIGM, FDA IDE, 50 patients, 5 US centers (Brigham, Mayo, Cleveland Clinic, AdventHealth, HCA)"},{"label":"FDA Status","value":"Final stage approved (Jan 2026). First robotic ESD by gastroenterologist (Oct 2025)."},{"label":"Total Funding","value":"$176M (Series D-2, Crescent Enterprises + Dr. Fred Moll co-led)"},{"label":"Partnership","value":"NVIDIA IGX Thor integration for AI-powered vision"},{"label":"CEO","value":"Eduardo Fonseca"}],"aliases":["EndoQuest"],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-07-22T21:32:37.672Z","updatedAt":"2026-10-10T14:59:29.186Z"}},"version":null,"location":{"id":"63e09f85-2dc7-4e87-a172-6f58dcb3673a","name":"Boston, Massachusetts, USA","slug":"boston-massachusetts-usa","kind":"city","parentLocationId":"01a88488-e42a-42af-97af-8ab887f4d917","region":"North America","lat":42.3588336,"lng":-71.0578303,"reviewStatus":"reviewed","aliases":["Boston, MA","Boston, Massachusetts, USA","Greater Boston","Boston","Boston MA"],"collisionRisk":"moderate","reviewNote":"Verified — Boston, Massachusetts, USA. 5 deployments: QinetiQ Talon (ended 2013), Waymo Driver Gen6 pilot (2025), Liberty Endovascular pilot (2024), EndoQuest ELS pilot (2022), HistoSonics Edison operational (2024). Existing coords 42.36N, 71.06W confirmed.","createdAt":"2026-08-08T20:16:29.044Z","updatedAt":"2026-11-02T18:32:15.604Z"},"operator":{"id":"06e82f4d-e2d5-4a09-a089-c752f2f22056","name":"EndoQuest Robotics","slug":"endoquest","description":"Houston-based endoluminal robotic surgery company. CEO Eduardo Fonseca. Endoluminal Surgical (ELS) System — flexible robot for scar-free procedures through natural orifices. PARADIGM Trial: FDA-approved final stage (Jan 2026), 50 patients, 5 US centers (Brigham, Mayo, Cleveland Clinic, AdventHealth, HCA). First robotic ESD by gastroenterologist in IDE trial (Oct 2025). Series D-2 co-led by Crescent Enterprises + Dr. Fred Moll ([Intuitive surgical](/companies/intuitive-surgical) co-founder). NVIDIA IGX Thor integration for AI vision. $176M total raised.","status":"private","founded":null,"hq":"Houston, TX","hqLat":29.7589382,"hqLng":-95.3676974,"hqGeocodedAt":"2026-08-05T14:28:12.044Z","hqAddress":null,"hqPrecision":null,"website":"endoquestrobotics.com","fundingTotal":"176000000","type":"hardware","roles":["robot_maker","robot_operator"],"reviewStatus":"reviewed","heatIndex":77,"lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://www.massdevice.com/endoquest-gets-fda-green-light-to-initiate-final-stage-of-surgical-robot-trial/","title":"EndoQuest FDA green light PARADIGM","sourceName":"MassDevice","dateAccessed":"2026-07-22"},{"url":"https://finance.yahoo.com/news/endoquest-robotics-secures-series-d-120000732.html","title":"EndoQuest Series D-2 Funding","sourceName":"Yahoo Finance/GlobeNewswire","dateAccessed":"2026-07-22"},{"url":"https://www.businesswire.com/news/home/20260112765182/en/EndoQuest-to-Bring-AI-Powered-Vision-and-Precision-to-Endoluminal-Robotic-Surgery-with-NVIDIA-IGX-Thor","title":"EndoQuest NVIDIA IGX Thor","sourceName":"BusinessWire","dateAccessed":"2026-07-22"}],"keyFacts":[{"label":"Product","value":"Endoluminal Surgical (ELS) System, flexible endoluminal robot"},{"label":"Trial","value":"PARADIGM, FDA IDE, 50 patients, 5 US centers (Brigham, Mayo, Cleveland Clinic, AdventHealth, HCA)"},{"label":"FDA Status","value":"Final stage approved (Jan 2026). First robotic ESD by gastroenterologist (Oct 2025)."},{"label":"Total Funding","value":"$176M (Series D-2, Crescent Enterprises + Dr. Fred Moll co-led)"},{"label":"Partnership","value":"NVIDIA IGX Thor integration for AI-powered vision"},{"label":"CEO","value":"Eduardo Fonseca"}],"aliases":["EndoQuest"],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-07-22T21:32:37.672Z","updatedAt":"2026-10-10T14:59:29.186Z"},"owner":null,"derived":{"trustTier":"unverified","currentPosture":null},"jsonLd":{"@context":"https://schema.org","@type":"Event","@id":"https://registry.deploy.report/deployments/endoquest-els-boston-massachusetts-usa","url":"https://registry.deploy.report/deployments/endoquest-els-boston-massachusetts-usa","name":"Endoluminal Surgical (ELS) System at Boston, Massachusetts, USA","identifier":"73823d83-172b-4f1f-9730-e739c322d9cd","startDate":"2022-08-01T00:00:00.000Z","location":{"@type":"Place","@id":"https://registry.deploy.report/locations/boston-massachusetts-usa","name":"Boston, Massachusetts, USA"},"organizer":{"@type":"Organization","@id":"https://registry.deploy.report/companies/endoquest","name":"EndoQuest Robotics"},"about":{"@type":"Product","@id":"https://registry.deploy.report/models/endoquest-els","name":"Endoluminal Surgical (ELS) System"},"publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":"pilot","lifecycle_state":"active","architectural_position":{"cohort":"surgical","sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":1,"primary_source_types":[]}}}